Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
US11345917B2 · kind B2 · utility
12Cited by
37References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 6, 2019 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | Nov 6, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to novel targets for angiogenic disorders. Novel oligonucleotides are also provided. Methods of using the novel oligonucleotides for the treatment of angiogenic disorders (e.g., preeclampsia) are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.